empty
05.02.2025 12:44 AM
Pfizer Stock Rises: Why Now is the Best Time to Trade?

On Tuesday, shares of Pfizer Inc. rose by 1.7% in pre-market trading following the release of its Q4 2024 financial report, which exceeded analysts' expectations.

The American pharmaceutical giant reported a net profit of $410 million, or 7 cents per share. This represents a significant improvement compared to a loss of $3.37 billion, or 60 cents per share, during the same period last year.

The company's revenue increased by 22%, totaling $17.76 billion, compared to $14.57 billion in Q4 2023. This performance surpassed FactSet's consensus estimate of $17.35 billion.

This image is no longer relevant

This growth is primarily due to a one-time non-cash revenue return of $3.5 billion associated with its antiviral drug Paxlovid. Additionally, there has been an increase in sales from the Seagen oncology portfolio, the Vyndaqel family for cardiovascular treatment, and overall growth in Paxlovid sales.

Total sales of Paxlovid reached $727 million, a significant improvement compared to the $3.14 billion loss recorded last year, which stemmed from the transition to a traditional commercial sales model in the U.S.

Furthermore, Pfizer experienced a positive impact from currency fluctuations, which added an extra $62 million to its overall revenue. The company's management has reaffirmed its forecast for 2025, projecting revenue between $61 billion and $64 billion, with adjusted earnings per share ranging from $2.80 to $3.00.

According to FactSet, the average analyst expectations are for revenue of $63.07 billion and earnings of $2.91 per share.

Pfizer's CFO, David Denton, expressed confidence that the company will return to pre-pandemic operational margin levels in the coming years and achieve total cost savings of $4.5 billion by the end of 2025.

This situation presents several opportunities for traders. Pfizer's stock has risen following a strong earnings report, which may indicate a continuation of this upward trend, making the company's shares attractive for short- and medium-term speculative trades.

Furthermore, considering the company's long-term prospects in innovative drug development, Pfizer remains a promising asset for investors seeking stable capital growth.

Access to Pfizer shares and other leading global companies is available through the InstaForex trading platform.

Fast order execution, a wide range of instruments including CFDs on U.S. stocks, and no deposit restrictions enable traders to respond swiftly to market changes.

The availability of leverage up to 1:1000 and low commissions also provides additional opportunities for effective capital management.

Given the high volatility in the pharmaceutical sector and the upcoming release of key data on drug sales, investors should monitor Pfizer's stock closely.

In the upcoming quarters, the company is expected to continue growing its revenue by expanding its portfolio of prescription drugs, which could lead to further increases in its share prices.

Ekaterina Kiseleva,
Analytical expert of InstaForex
© 2007-2025
Select timeframe
5
min
15
min
30
min
1
hour
4
hours
1
day
1
week
Earn on cryptocurrency rate changes with InstaForex
Download MetaTrader 4 and open your first trade
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST

Recommended Stories

What could tip USD: NFP, Fed moves, or Big Beautiful Bill?

Wall Street keeps churning out record after record. On Wednesday, the S&P 500 , driven by IT giants, once again set a fresh all-time high. The catalyst was not only

Svetlana Radchenko 13:17 2025-07-03 UTC+2

US Market News Digest for July 3

The S&P 500 index once again reached an all-time high thanks to sustained demand for technology stocks and a positive reaction to the US-Vietnam trade agreement on tariffs. Investors

Ekaterina Kiseleva 12:58 2025-07-03 UTC+2

Stocks Ride: Nasdaq Jumps, S&P Rises, Dow Falls — There's More Behind It

Nasdaq Closes 0.94%; S&P 500 Up 0.47%; Dow Down 0.02% Centene Falls After Cutting 2025 Outlook Tesla Rises, Rebounds From Early Week Losses Wall Street Futures Up 0.1%, Nikkei Flat

Thomas Frank 10:28 2025-07-03 UTC+2

US Market News Digest for July 2

The S&P 500 index declined by 0.11%, the Nasdaq 100 lost 0.82%, while the Dow Jones rose by 0.91%. Investors are awaiting the release of macroeconomic data that could influence

Ekaterina Kiseleva 12:32 2025-07-02 UTC+2

Tesla falls, European stocks rise

Tesla Shares Fall as Musk-Trump Feud Renews Powell Doesn't Rule Out July Rate Cut Mixed Signals in US Manufacturing Labor and Contracts European Stocks Rise on Wednesday, Led by Industrial

Thomas Frank 10:56 2025-07-02 UTC+2

Stock Market Rises Higher: What's Pushing Dow, Nasdaq, S&P Higher

Bank Stocks Rise After Fed Stress Test Tesla Shares Fall Gold Rises as Oil Prices Fall on OPEC+ Output Expectations Zealand Pharma Gains After BNP Opens Coverage with 'Outperformance' InPost

Thomas Frank 12:11 2025-07-01 UTC+2

US Market News Digest for July 1

Monday's trading ended in positive territory: the S&P 500 rose by 0.52%, while the Nasdaq 100 added 0.47%. The start of the second half of the year unfolded amid optimistic

Ekaterina Kiseleva 11:43 2025-07-01 UTC+2

What could Bitcoin encounter in July? Market grimaces

The second month of summer is traditionally considered a favorable period for Bitcoin. It's quite possible that the pattern will repeat this year, and BTC may begin its ascent toward

Larisa Kolesnikova 10:58 2025-07-01 UTC+2

US Market News Digest for June 30

US equity markets closed higher: the S&P 500 and Nasdaq 100 both gained 0.52%, while the Dow Jones rose by 1.00%. Investors welcomed progress in trade negotiations, which

Ekaterina Kiseleva 11:15 2025-06-30 UTC+2

Hedge funds sell energy at record pace - what are they afraid of?

Hedge funds sold energy stocks last week at the fastest pace since September 2024 and the second fastest in 10 years as oil prices fell on easing tensions

Thomas Frank 11:14 2025-06-30 UTC+2
Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.